# Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

> **NCT01017172** · PHASE4 · UNKNOWN · sponsor: **Goethe University** · enrollment: 500 (estimated)

## Conditions studied

- HIV-1 Infection
- Cancer
- Immunosuppression

## Interventions

- **OTHER:** serologic testing

## Key facts

- **NCT ID:** NCT01017172
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2009-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017172, "Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01017172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*